(Q42327741)

26 October 2017

0 references

Killing AML: RIPK3 leads the way. (English)

1 reference

26 October 2017

Philipp J Jost

3

1 reference

ORCID Public Data File 2021

author name string

Ulrike Höckendorf

series ordinal

1

1 reference

PMC publication ID

5270541

26 October 2017

Monica Yabal

series ordinal

2

1 reference

26 October 2017

11 October 2016

1 reference

26 October 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

Cell Cycle

1 reference

26 October 2017

16

1 reference

26 October 2017

1

1 reference

26 October 2017

3-4

1 reference

RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

RIP3 induces apoptosis independent of pronecrotic kinase activity

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5270541

10.1080/15384101.2016.1232069

17 August 2018

Identifiers

DOI

1 reference

26 October 2017

1 reference

PMC publication ID

5270541

26 October 2017

PubMed publication ID

27726465

1 reference

PMC publication ID

5270541